Thursday 28 Mar 2024
By
main news image

SINGAPORE (June 3): Swiss pharmaceutical company Lonza has announced on June 2, that it has expanded its collaboration with biotech company Moderna.

This comes after the announcement of a 10-year strategic collaboration agreement signed between both companies in May 2020 to enable the manufacture of the Moderna Covid-19 vaccine and additional Moderna products in future.

The expanded partnership will see Lonza extending...(click on link for full story on theedgesingapore.com)

      Print
      Text Size
      Share